TSI buys Raman specialist Enwave Optronics

Published: 26-Feb-2014
Finance Analysis

Expands further into the chemical characterisation market


TSI, a precision instrumentation specialist based in Minnesota, US, has purchased the business assets and Raman spectroscopy technology from Enwave Optronics.

The acquisition expands TSI's ChemLogix family of chemical analysis solutions.

No financial details have been revealed.

Enwave Optronics, based in Irvine, California, has developed and commercialised a range of precision Raman instruments. Products include handheld, portable, bench top and installed process control instruments.

The purchase of the Raman spectroscopy technology builds on TSI's 2012 acquisition of Laser-Induced Breakdown spectroscopy (LIBS) technology for elemental analysis of solid materials from PhotonMachines.

TSI's President, Tom Kennedy, said: 'Raman technology expands our chemical characterisation business so that now we can address molecular-based as well as elemental-based material analysis. Both Raman and LIBS technology also support growth initiatives across several of our current core businesses.'

  • Companies:
  • TSI Instruments
See more

You may also like

Manufacturing

How to improve yield while reliably monitoring clean manufacturing environments

Read more
New Aerotrak + Remote Airborne Particle Counters help to minimise costs, waste and risk

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  4. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  5. Fluidic Sciences relaunches Microfluidic Diffusional Sizing technology to refine protein-protein interaction analysis The Microfluidic Diffusional Sizing (MDS) technology allows scientists better options when characterising a protein's biophysical properties

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

How to improve yield while reliably monitoring clean manufacturing environments

New Aerotrak + Remote Airborne Particle Counters help to minimise costs, waste and risk
Analysis

Ashtead Technology and TSI renew Gold Partnership

Companies to deliver joint activities such as free air quality training events
Analysis

TSI and Testo measurement technologies demo

At AQE 2017, the companies' measuring equipment solutions will be presented by Ashtead Technology
Analysis

TSI markets new laser aerosol spectrometer

The 3340 Laser Aerosol Spectrometer, recently launched by TSI inc, is a high resolution multi-purpose airborne particle sizer that can measure particles from 0.09 to 7.5 microns at concentrations up to 18,000 particle/cm<sup>3</sup>. Complete size distributions are measured in less than a second with up to 100 user configurable channels of data.
Finance

Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China

New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
Finance

Newcells Biotech raises additional funding from investors

Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
Research & Development

Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research

The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
Subscribe now